Organoid Transplantation and Tissue Replacement

What Organoid Transplantation Means

Organoids are grown from tissue-resident stem cells or pluripotent stem cells under conditions that allow cells to self-organize into some of the structures and cell populations found in a tissue. Their degree of fidelity varies by protocol: an intestinal epithelial organoid, a retinal sheet, and a multicellular liver bud are biologically different products even though all may be described as organoids. [1]

Transplantation places this cultured tissue into a living host. The intended outcome may be a patch of replacement epithelium, a local source of metabolic activity, reconstruction of a neural circuit, or a larger tissue graft connected to the host circulation. “Tissue replacement” therefore covers several levels of integration and should not be assumed to mean whole-organ substitution. [1] [2] [3]

What a Graft Must Accomplish

Evidence Across Tissue Types

Intestinal epithelium provides a relatively direct example of local tissue repair. Mouse colonic organoids expanded from adult Lgr5-positive stem cells engrafted into experimentally injured colon, formed a continuous epithelial layer, and persisted for more than six months. This demonstrated durable epithelial replacement in mice, but not replacement of the bowel wall, nervous system, vasculature, or motility apparatus. [2]

Human induced-pluripotent-stem-cell-derived liver buds containing hepatic, endothelial, and mesenchymal cells connected rapidly to host vessels after transplantation into immunodeficient mice. The grafts produced human liver proteins and showed drug-metabolism activity, providing proof of principle for a vascularized metabolic tissue. Their small scale and ectopic implantation distinguish them from a transplantable human liver. [3]

Kidney organoids transplanted beneath the renal capsule of mice developed perfused glomerular vessels and showed greater glomerular and tubular maturation than matched organoids kept in vitro. A separate analysis nevertheless found persistent immaturity and off-target tissues in transplanted kidney organoids, illustrating that vascularization does not by itself create a complete filtering organ with urinary drainage. [4] [7]

Neural organoid grafts in adult mouse brain became vascularized, matured, extended axons, and displayed neuronal activity with evidence consistent with graft-to-host synaptic connectivity. In a mouse stroke model, transplanted human cerebral organoids survived in an injury cavity and were associated with circuit integration and improved sensorimotor outcomes. These are preclinical studies in immunodeficient rodents, not evidence that human cortical tissue can yet be safely reconstructed. [5] [8]

Retinal organoid sheets have also been studied as organized grafts. Human embryonic-stem-cell-derived retinal tissue survived and matured after transplantation in primate retinal-degeneration models, with no tumors observed during the reported study periods. Evidence of host–graft contact was present, but the study did not establish restoration of vision in humans. [6]

Why In-Vivo Maturation Helps but Does Not Solve Replacement

Culture systems often lack perfused vasculature, circulating immune cells, innervation, organ-scale mechanical forces, and the full developmental signalling environment. Transplantation can supply some of these missing inputs, which helps explain why kidney and neural organoids mature further in vivo. The same dependence also makes outcomes sensitive to graft site, host species, immune suppression, and injury environment. [1] [4] [5]

Functional organs also require architecture beyond local cell identity. A kidney graft needs filtration connected to collecting ducts and urinary outflow; liver tissue needs vascular and biliary organization; neural tissue needs appropriate long-range connectivity. Current experiments usually reproduce only a subset of these requirements. [3] [4] [7]

Translational Constraints

• Product definition: Cell composition, developmental stage, size, and function can vary between stem-cell lines and culture batches, so identity and potency tests must be specific to the intended graft. [1]
• Scale and perfusion: Diffusion supports only limited tissue thickness; larger grafts need rapid, stable vascular connections and an architecture that distributes flow. [3] [4]
• Immune compatibility: Allogeneic cells may be rejected, while autologous production is slower and does not remove risks introduced during reprogramming, expansion, or differentiation. [1]
• Unwanted growth: Residual pluripotent cells, proliferative progenitors, genetic abnormalities, or off-target tissues require sensitive testing because a graft may persist for years. [7]
• Delivery and integration: Surgery must place tissue without damaging the host and must establish the organ-specific connections needed for useful function. [2] [6]
• Interpretation: Increased graft size, marker expression, or vascular density is not equivalent to restored organ function or improved long-term clinical outcomes. [4] [7]

Relevance to Ageing

Age-related disease can involve the irreversible loss of specialized cells and tissue architecture, so replacement research addresses a different question from attempts to modify ageing pathways in cells that remain present. Organoid grafts could in principle restore a localized tissue function without altering the many systemic processes associated with ageing. [1] [2]

Older recipients may also present a less supportive environment for engraftment because vascular, immune, fibrotic, and extracellular-matrix conditions differ from those in young laboratory animals. Since many published transplantation experiments use young or immunodeficient hosts, their results do not demonstrate rejuvenation or predict performance in older humans. [3] [4] [5]

Evidence Quality and Interpretation

Confidence is high that selected organoids can survive transplantation and undergo additional vascularization or maturation in animal hosts. Confidence is moderate that some grafts can replace a localized epithelial function or contribute measurable activity in specific preclinical models. Confidence is low that current organoid systems can replace a whole complex organ or provide durable, safe benefit for age-related disease in humans, because evidence remains dominated by small-animal and non-human-primate studies with tissue-specific endpoints. [2] [3] [4] [6]

Summary

Organoid transplantation uses organized, stem-cell-derived tissue as a graft rather than delivering dissociated cells alone. Preclinical studies demonstrate durable epithelial engraftment, host-supported vascularization, further maturation, and selected forms of functional integration. The central research challenge is to convert these local proofs of principle into reproducible grafts with the scale, architecture, connections, safety, and long-term function required for human tissue replacement. [1] [2] [7]

References

1. Kim, J. et al. (2022). Organoids. Nature Reviews Methods Primers. https://doi.org/10.1038/s43586-022-00174-y
2. Yui, S. et al. (2012). Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5+ stem cell. Nature Medicine. https://doi.org/10.1038/nm.2695
3. Takebe, T. et al. (2013). Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature. https://doi.org/10.1038/nature12271
4. van den Berg, C. W. et al. (2018). Renal subcapsular transplantation of PSC-derived kidney organoids induces neo-vasculogenesis and significant glomerular and tubular maturation in vivo. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2018.01.041
5. Mansour, A. A. et al. (2018). An in vivo model of functional and vascularized human brain organoids. Nature Biotechnology. https://doi.org/10.1038/nbt.4127
6. Shirai, H. et al. (2016). Transplantation of human embryonic stem cell-derived retinal tissue in two primate models of retinal degeneration. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1512590113
7. Nam, S. A. et al. (2019). Graft immaturity and safety concerns in transplanted human kidney organoids. Experimental & Molecular Medicine. https://doi.org/10.1038/s12276-019-0336-x
8. Cao, S.-Y. et al. (2023). Cerebral organoids transplantation repairs infarcted cortex and restores impaired function after stroke. npj Regenerative Medicine. https://doi.org/10.1038/s41536-023-00301-7